RAETTA WENTZ: Open Payments
NPI 1740508779 · BRIDGEPORT, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 38 payments from 10 companies in 2025. Trend: 2023 $553 · 2024 $739 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $193 |
| AstraZeneca Pharmaceuticals LP | 5 | $161 |
| Novo Nordisk Inc | 4 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $69 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Exact Sciences Corporation | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: BRILINTA, VRAYLAR, XIFAXAN, UBRELVY, SHINGRIX, Ozempic, JARDIANCE, Rybelsus.
Industry payments across WV — which companies pay providers there.
